US FDA approves Alcon's new dry-eye drug
Spun off from Novartis (NOVN.S), opens new tab in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of 2025 and beyond.
The approval was based on late-stage studies in which the liquid medication, Tryptyr, demonstrated natural tear production as early as day one.
The company said Tryptyr stimulates corneal sensory nerves to quickly increase natural tear production.
DED is a condition in which the eyes either do not produce enough tears or produce poor-quality tears, leading to discomfort and potentially affecting vision.
The company said about 38 million individuals in the United States suffer from DED, yet fewer than 10% of diagnosed patients are being treated with a prescription product.
Alcon, which produces contact lenses, dry eye drops, gels and other related products, expects to launch Tryptyr in the United States during the third quarter of 2025, with plans to introduce the treatment in other markets later.
Other FDA-approved treatments for DED include Alcon's Eysuvis and Bausch + Lomb's (BLCO.TO), opens new tab Xiidra.
Last month, however, the FDA declined to approve Aldeyra Therapeutics' (ALDX.O), opens new tab treatment for DED.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
13 minutes ago
- Reuters
Walmart's earnings report will test investor confidence in US market
NEW YORK, Aug 19 (Reuters) - Investors expect Walmart's (WMT.N), opens new tab management to strike a cautious tone on customer demand as the U.S. labor market cools and inflation ticks up, though the company has outperformed its peers over the last year due to its reliance on grocery sales and wealthier customers shopping there more often. Still, analysts say this environment is a sweet spot for Walmart, which reports second-quarter results on Thursday before markets open. Its low-price model and dominance in grocery can help it weather economic storms better than others. The world's largest retailer by sales has surpassed earnings estimates for 11 consecutive quarters, according to LSEG data, sending its valuation soaring even as other consumer staples companies have struggled this year. The Arkansas-based chain's stock has gained nearly 37% in the last 12 months, one of the notable non-tech companies leading a market that has largely sloughed off the effects of U.S. President Donald Trump's ongoing trade war. The broader Consumer Staples sector (.SPLRCS), opens new tab is up 4.5%, trailing the broad-market S&P 500. The company's May-to-July results are the most closely watched event among this week's retail earnings, following Tuesday's results from Home Depot (HD.N), opens new tab and Wednesday's reports from Lowe's (LOW.N), opens new tab and Target (TGT.N), opens new tab. Its significance goes beyond retail; as one of the largest and most recognizable companies in the U.S., Walmart is viewed as a barometer for the state of the U.S. consumer. "Walmart essentially is middle America, so I'll be looking for cues from Walmart as to the health of the broader economy," said Charles Sizemore, a Walmart investor. U.S. shoppers remain resilient despite declining sentiment, but they are being increasingly selective about purchases and have shown signs of trading down. RBC Capital Markets analyst Steven Shemesh cautioned that Walmart may adopt a more cautious tone heading into the second half. "The million-dollar question at this point is how customers respond to higher prices. We have seen some higher prices to date, and the consumer has managed through them OK, and we haven't seen a material impact to volume. But I don't think they're very widespread price increases at this point where the consumer has really noticed," Shemesh said. Home Depot (HD.N), opens new tabmissed estimates for quarterly revenue and profit, but kept its annual forecasts intact on Tuesday. Walmart's forward price-to-earnings ratio currently stands at 35.7, compared with an average of 25.5 over the past five years, suggesting investors expect growth. Its market value has soared to about $800 billion, per LSEG Datastream. Investors and analysts expect the retailer to report earnings of 74 cents a share, up nearly 11% from a year ago, and revenue of $176.16 billion, up 4%. Sales fell slightly short of expectations in Walmart's last quarter, but July's retail sales report bolstered analysts' confidence in current spending trends. "July's data showing retail sales grew faster than inflation tells me that the consumer is still spending and unit counts are up," said D.A. Davidson analyst Michael Baker. Reuters' global tariff tracker shows at least 92 out of nearly 300 companies have announced price hikes in response to the trade war, with about one-third from the consumer sectors. That includes Tide detergent and Bounty paper towels maker Procter & Gamble (PG.N), opens new tab, a top Walmart supplier. "Third quarter is the make-or-break quarter, really, where the higher prices ... are going to be passed along in a more broader way than what we are seeing now," Shemesh said.
Daily Mail
14 minutes ago
- Daily Mail
Deadly vapor claims fifth Manhattan victim: Doctors list no-go areas... and reveal 'mind-altering' symptoms that mimic flu but can kill in days
New York has recorded a fifth death in a deadly outbreak of Legionnaires' disease - a lung infection spread by toxic water vapor - sparking fears of more victims across the city. The city announced Monday that, since an outbreak in late July, 108 people have been infected with Legionnaire's disease, a type of pneumonia that spreads through bacteria lurking in warm later.
Daily Mail
14 minutes ago
- Daily Mail
Poll: Trump hits lowest approval rating this year
Support for Donald Trump has tumbled as his term has progressed, with the latest poll showing his approval rating at its lowest point all year. The latest Reuters/Ipsos poll of nearly 4,500 Americans found that the president is carrying a 40 percent approval rating. That level of support, the lowest of the president's second term, ties Trump's approval rating from the same pollsters just weeks ago in late July. Trump's disapproval rating ticked slightly down in the latest survey to 54 percent. The 79-year-old president's disapproval stood at 56 percent as of July 27. It is a seven-point drop in support for the president from the beginning of his term, when Trump had a 47 percent approval rating. At this point in his term, former President Joe Biden maintained a 50 percent approval rating, according to a Reuters/Ipsos poll taken in August 2021. The slumping approval rating comes amid signs that the U.S. economy is weakening and high-stakes diplomatic negotiations with Russia and Ukraine to end their ongoing war continue. Over half of the respondents, 54 percent, including a quarter of Republicans, said they believe Trump is too closely aligned with Russia. Notably, Trump bled support among Hispanics as he oversees a sweeping nationwide immigration crackdown that has led to at least 300,00 repatriations. Just 32 percent of Hispanics in the latest Reuters/Ipsos survey approved of the president's performance. Support for Trump came predominantly from registered Republicans. Only 42 percent of respondents voiced support for the president's performance on crime, and 43 percent said he is doing a good job on immigration. Other recent polls, meanwhile, have shown more support for the president's job performance. According to the RealClearPolitics polling average, Trump's approval sits at 46 percent while his disapproval rating is 51 percent.
